Divya Srivastava
Contact details
Personal links
About
Overview
Dr. Divya Srivastava is Programme Director of the MSc Health Management and a Senior Lecturer in the School of Health and Medical Sciences. She is a health economist with expertise in health financing, digital health technologies and comparative health policy.
Divya's current research looks at the intersection between economics, digital health technologies including AI involving methods for analysis and health financing. She leads the AI and Digital Health Lab in the Centre for Healthcare Innovation Research at City St George's, University of London. She is the founder of the Special Interest Group in the Economics of Digital Health Technology under the auspices of the International Health Economics Association. She holds a Visiting Senior Fellow position in the Department of Health Policy (LSE), a Data Science Affiliate (LSE) and holds an honoray academic appointment with the UKHSA.
Her work has been published in various journals including Social Science and Medicine, BMJ Global Health, BMC Public Health and Applied Economics. She has worked for the Organisation for Economic Cooperation and Development (OECD), where she led projects on provider payment reform and geographic variations in health care to understand health system performance, the WHO European Observatory on Health Systems and Policies, and for national institutions (Canada, UK).
Divya holds a BSc Statistics Honours (University of Manitoba, Canada), MA Economics (McMaster University, Canada), MSc IHP (Brian Abel-Smith Award for Best Dissertation) and a PhD (Merck Scholar) from the London School of Economics and Political Science.
Her current funding research includes an NIHR Phase IV award (£125,000) to conduct an economic evaluation of an AI technology to support the diagnosis of breast cancer. (August 2024 to December 2025).
She welcomes PhD proposals at the intersection of AI, or digital health and economics using empircal methods for analysis.
Qualifications
- PhD Health Economics (Merck Scholar), London School of Economics and Political Science, United Kingdom
- MSc International Health Policy (Brian Abel-Smith Best Dissertation), London School of Economics and Political Science, United Kingdom
- M.A. Economics, McMaster University, Canada
- BSc. Honours Statistics, University of Manitoba, Canada
Postgraduate training
- PGCert, London School of Economics and Political Science, London, United Kingdom
Employment
- Programme Director, MSc Health Management, City St George's, University of London, United Kingdom, January 2026 - present
- Senior Lecturer, City St George's, University of London, United Kingdom, August 2025 - present
- Honorary Academic Fellow, UK Health Security Agency, United Kingdom, May 2025 - May 2027
- Visiting Senior Fellow, London School of Economics and Political Science, United Kingdom, May 2024 - present
- Lecturer/Assistant Professor in Research Methods, City, University of London, United Kingdom, April 2024 - July 2025
- Guest Teacher, London School of Economics and Political Science, United Kingdom, October 2021 - April 2024
Languages
French and Hindi
Research
NIHR Award AI in breast cancer
PI of Health Economics Work Package: £125,000, August 2024-December 2025
Publications
Publications by category
Journal articles (17)
- Laan, B.L.H., Peute, L. and Srivastava, D. (2026). Exploring Healthcare Providers’ Expectations and Perceptions of AI Machine Learning Decision Tree Models in Healthcare. . doi:10.3233/shti260267
- Greggio, J., Stogiannos, N., Stewart, K.L., Srivastava, D., Hirani, S.P., Hilton, S.... Malamateniou, C. (2026). Exploring digital twinning in MRI: A systematic review of current applications, barriers, and future opportunities. Radiography, 32(4), pp. 103413-103413. doi:10.1016/j.radi.2026.103413
- Orgad, S., Srivastava, D. and Olaleye, D. (2025). Listening in times of crisis: The value and limits of radio phone-in shows. Media, Culture & Society, 47(4), pp. 753-770. doi:10.1177/01634437241308729
- Connolly, G., Costa-Font, J. and Srivastava, D. (2025). Did COVID-19 reduce the digital divide? A systematic review. Health Policy and Technology, 14(2), pp. 100979-100979. doi:10.1016/j.hlpt.2025.100979
- Gille, F., Maaß, L., Ho, B. and Srivastava, D. (2025). From Theory to Practice: Viewpoint on Economic Indicators for Trust in Digital Health. Journal of Medical Internet Research, 27, pp. e59111-e59111. doi:10.2196/59111
- Srivastava, D. (2024). AI: A Use Case for Global Health. LSE Public Policy Review, 3(3). doi:10.31389/lseppr.109
- Elvidge, J., Hawksworth, C., Avşar, T.S., Zemplenyi, A., Chalkidou, A., Petrou, S.... Wilson, E. (2024). Consolidated Health Economic Evaluation Reporting Standards for Interventions That Use Artificial Intelligence (CHEERS-AI). Value in Health, 27(9), pp. 1196-1205. doi:10.1016/j.jval.2024.05.006
- Srivastava, D., Van Kessel, R., Delgrange, M., Cherla, A., Sood, H. and Mossialos, E. (2023). A Framework for Digital Health Policy: Insights from Virtual Primary Care Systems Across Five Nations. PLOS Digital Health, 2(11), pp. e0000382-e0000382. doi:10.1371/journal.pdig.0000382
- Srivastava, D., Henschke, C., Virtanen, L., Lotman, E.-.M., Friebel, R., Ardito, V.... Petracca, F. (2023). Promoting the systematic use of real-world data and real-world evidence for digital health technologies across Europe: a consensus framework. Health Economics, Policy and Law, 18(4), pp. 395-410. doi:10.1017/s1744133123000208
- van Kessel, R., Srivastava, D., Kyriopoulos, I., Monti, G., Novillo-Ortiz, D., Milman, R.... Mossialos, E. (2023). Digital Health Reimbursement Strategies of 8 European Countries and Israel: Scoping Review and Policy Mapping. JMIR mHealth and uHealth, 11, pp. e49003-e49003. doi:10.2196/49003
- Bigio, J., Hannay, E., Pai, M., Alisjahbana, B., Das, R., Huynh, H.B.... Srivastava, D. (2023). The inclusion of diagnostics in national health insurance schemes in Cambodia, India, Indonesia, Nepal, Pakistan, Philippines and Viet Nam. BMJ Global Health, 8(7), pp. e012512-e012512. doi:10.1136/bmjgh-2023-012512
- Elshaug, A.G., Rosenthal, M.B., Lavis, J.N., Brownlee, S., Schmidt, H., Nagpal, S.... Saini, V. (2017). Levers for addressing medical underuse and overuse: achieving high-value health care. The Lancet, 390(10090), pp. 191-202. doi:10.1016/s0140-6736(16)32586-7
- Brownlee, S., Chalkidou, K., Doust, J., Elshaug, A.G., Glasziou, P., Heath, I.... Korenstein, D. (2017). Evidence for overuse of medical services around the world. The Lancet, 390(10090), pp. 156-168. doi:10.1016/s0140-6736(16)32585-5
- Srivastava, D. and McGuire, A. (2016). The determinants of access to health care and medicines in India. Applied Economics, 48(17), pp. 1618-1632. doi:10.1080/00036846.2015.1105921
- Srivastava, D. and McGuire, A. (2015). Patient access to health care and medicines across low-income countries. Social Science & Medicine, 133, pp. 21-27. doi:10.1016/j.socscimed.2015.03.021
- Srivastava, D. and McGuire, A. (2014). Analysis of prices paid by low-income countries - how price sensitive is government demand for medicines? BMC Public Health, 14(1). doi:10.1186/1471-2458-14-767
- Corallo, A.N., Croxford, R., Goodman, D.C., Bryan, E.L., Srivastava, D. and Stukel, T.A. (2014). A systematic review of medical practice variation in OECD countries. Health Policy, 114(1), pp. 5-14. doi:10.1016/j.healthpol.2013.08.002
Professional activities
Events/conferences (6)
- Economist Impact Future of Health Summit. (2025). Panel Member
-
International Health Economics Association Congress. (Conference) (2025).
Paper: Integrating Virtual Primary Care: Evidence and learnings from LMICs -
International Health Economics Association Congress. (2025).
Paper: Economic Evaluation of AI in the diagnosis of breast cancer - Innovation in Women’s Health Tech 2025. (2025). Panel Member
-
City St George's Launch Event. (2025). Panel Member
Paper: How can AI contribute to the future health of the nation -
European Health Economics Conference. (2024). Chair and Session/Day Chair
Paper: Uptake of remote appointments in primary care
Keynote lecture/speech
- Institute of Directors, Japan Business Group Symposium on Health & Life Sciences. (2025).